InterVene is a product of the Stanford Biodesign Fellowship program and a former Company-In-Residence at the Fogarty Institute for Innovation.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 06/25/19 | $15,000,000 | Series B |
3x5 Partners Boston Scientific Correlation Ventures RiverVest Venture Partners | undisclosed |
